These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23038624)

  • 21. Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure.
    Frystyk J; Ivarsen P; Skjaerbaek C; Flyvbjerg A; Pedersen EB; Orskov H
    Kidney Int; 1999 Dec; 56(6):2076-84. PubMed ID: 10594783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the quantitative balance between insulin-like growth factor (IGF)-1 ligand, receptor, and binding protein levels to predict cell sensitivity and therapeutic efficacy.
    Tian D; Kreeger PK
    BMC Syst Biol; 2014 Aug; 8():98. PubMed ID: 25115504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin growth factor adjustment in preimplantation rabbit blastocysts and uterine tissues in response to maternal type 1 diabetes.
    Thieme R; Schindler M; Ramin N; Fischer S; Mühleck B; Fischer B; Navarrete Santos A
    Mol Cell Endocrinol; 2012 Jul; 358(1):96-103. PubMed ID: 22465205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
    Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-like growth factor (IGF) binding protein-3 inhibits type 1 IGF receptor activation independently of its IGF binding affinity.
    Ricort JM; Binoux M
    Endocrinology; 2001 Jan; 142(1):108-13. PubMed ID: 11145572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation.
    Juul A; Dalgaard P; Blum WF; Bang P; Hall K; Michaelsen KF; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2534-42. PubMed ID: 7543116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?
    Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K
    Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity.
    Clemmons DR; Moses AC; McKay MJ; Sommer A; Rosen DM; Ruckle J
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1518-24. PubMed ID: 10770191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of raloxifene and estrogen on bioactive IGF1 in GH-deficient women.
    Birzniece V; Magnusson NE; Ho KK; Frystyk J
    Eur J Endocrinol; 2014 Mar; 170(3):375-83. PubMed ID: 24347426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pituitary-independent effect of octreotide on IGF1 generation.
    Pokrajac A; Frystyk J; Flyvbjerg A; Trainer PJ
    Eur J Endocrinol; 2009 Apr; 160(4):543-8. PubMed ID: 19141605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating bioactive and immunoreactive IGF-I remain stable in women, despite physical fitness improvements after 8 weeks of resistance, aerobic, and combined exercise training.
    Nindl BC; Alemany JA; Tuckow AP; Rarick KR; Staab JS; Kraemer WJ; Maresh CM; Spiering BA; Hatfield DL; Flyvbjerg A; Frystyk J
    J Appl Physiol (1985); 2010 Jul; 109(1):112-20. PubMed ID: 20395543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of insulin-like growth factor 1 and its receptor in the formation and development of colorectal carcinoma.
    Zhang R; Xu GL; Li Y; He LJ; Chen LM; Wang GB; Lin SY; Luo GY; Gao XY; Shan HB
    J Int Med Res; 2013 Aug; 41(4):1228-35. PubMed ID: 23801064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interstitial fluid contains higher in vitro IGF bioactivity than serum: a study utilizing the suction blister technique.
    Espelund U; Søndergaard K; Bjerring P; Flyvbjerg A; Frystyk J
    Growth Horm IGF Res; 2012 Dec; 22(6):234-9. PubMed ID: 22939216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exercise-induced insulin-like growth factor I system concentrations after training in women.
    Gregory SM; Spiering BA; Alemany JA; Tuckow AP; Rarick KR; Staab JS; Hatfield DL; Kraemer WJ; Maresh CM; Nindl BC
    Med Sci Sports Exerc; 2013 Mar; 45(3):420-8. PubMed ID: 23034644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased levels of circulating free insulin-like growth factors in patients with non-islet cell tumour hypoglycaemia.
    Frystyk J; Skjaerbaek C; Zapf J; Orskov H
    Diabetologia; 1998 May; 41(5):589-94. PubMed ID: 9628278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraperitoneal insulin delivery to patients with type 1 diabetes results in higher serum IGF-I bioactivity than continuous subcutaneous insulin infusion.
    Hedman CA; Frystyk J; Lindström T; Oskarsson P; Arnqvist HJ
    Clin Endocrinol (Oxf); 2014 Jul; 81(1):58-62. PubMed ID: 23865977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ω-3 fatty acid differentially modulated serum levels of IGF1 and IGFBP3 in men with CVD: a randomized, double-blind placebo-controlled study.
    Gholamhosseini S; Nematipour E; Djazayery A; Javanbakht MH; Koohdani F; Zareei M; Djalali M
    Nutrition; 2015 Mar; 31(3):480-4. PubMed ID: 25701338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The IGF-system is not affected by a twofold change in protein intake in patients with type 1 diabetes.
    Hedman CA; Frystyk J; Fridell K; Jönsson A; Flyvbjerg A; Lindström T; Arnqvist HJ
    Growth Horm IGF Res; 2005 Aug; 15(4):304-10. PubMed ID: 16054412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Residual β-cell function and the insulin-like growth factor system in Danish children and adolescents with type 1 diabetes.
    Sorensen JS; Birkebaek NH; Bjerre M; Pociot F; Kristensen K; Hoejberg AS; Frystyk J;
    J Clin Endocrinol Metab; 2015 Mar; 100(3):1053-61. PubMed ID: 25532040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The IGF system in the neonatal ovine uterus.
    Hayashi K; Carpenter KD; Welsh TH; Burghardt RC; Spicer LJ; Spencer TE
    Reproduction; 2005 Mar; 129(3):337-47. PubMed ID: 15749960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.